385 related articles for article (PubMed ID: 18372573)
1. QT and TdP. QT: an unreliable predictor of proarrhythmia.
Hondeghem LM
Acta Cardiol; 2008 Feb; 63(1):1-7. PubMed ID: 18372573
[TBL] [Abstract][Full Text] [Related]
2. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability).
Hondeghem LM
Novartis Found Symp; 2005; 266():235-44; discussion 244-50. PubMed ID: 16050272
[TBL] [Abstract][Full Text] [Related]
3. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
Hondeghem LM
J Cardiovasc Electrophysiol; 2006 Mar; 17(3):337-40. PubMed ID: 16643415
[TBL] [Abstract][Full Text] [Related]
4. Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts.
Hondeghem LM
Prog Biophys Mol Biol; 2016 May; 121(1):3-10. PubMed ID: 26980523
[TBL] [Abstract][Full Text] [Related]
5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
6. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.
Shah RR; Hondeghem LM
Heart Rhythm; 2005 Jul; 2(7):758-72. PubMed ID: 15992736
[TBL] [Abstract][Full Text] [Related]
7. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
8. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
Lu HR; Gallacher DJ; Yan GX
J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776
[TBL] [Abstract][Full Text] [Related]
9. QT prolongation is an unreliable predictor of ventricular arrhythmia.
Hondeghem LM
Heart Rhythm; 2008 Aug; 5(8):1210-2. PubMed ID: 18675236
[TBL] [Abstract][Full Text] [Related]
10. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
Hondeghem LM
Drug Saf; 2018 Jan; 41(1):11-17. PubMed ID: 28853038
[TBL] [Abstract][Full Text] [Related]
11. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
Lawrence CL; Pollard CE; Hammond TG; Valentin JP
J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
[TBL] [Abstract][Full Text] [Related]
12. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
[TBL] [Abstract][Full Text] [Related]
13. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
Hondeghem LM; Carlsson L; Duker G
Circulation; 2001 Apr; 103(15):2004-13. PubMed ID: 11306531
[TBL] [Abstract][Full Text] [Related]
14. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
Said TH; Wilson LD; Jeyaraj D; Fossa AA; Rosenbaum DS
J Cardiovasc Pharmacol; 2012 Aug; 60(2):165-71. PubMed ID: 22561361
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
[TBL] [Abstract][Full Text] [Related]
16. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
Briasoulis A; Agarwal V; Pierce WJ
Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
18. QTc prolongation as a surrogate for drug-induced arrhythmias: fact or fallacy?
Hondeghem LM
Acta Cardiol; 2011 Dec; 66(6):685-9. PubMed ID: 22299377
[TBL] [Abstract][Full Text] [Related]
19. [Lengthening of QT interval by antipsychotic drugs].
Haverkamp W; Deuschle M
Nervenarzt; 2006 Mar; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
[TBL] [Abstract][Full Text] [Related]
20. A new preclinical biomarker for risk of Torsades de Pointes: drug-induced reduction of the cardiac electromechanical window.
Vargas HM
Br J Pharmacol; 2010 Dec; 161(7):1441-3. PubMed ID: 20698854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
